missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ RECTAS

Click to view available options
Quantity:
10 mg
50 mg
Unit Size:
10mg
50mg
Description
RECTAS (rectifier of aberrant splicing) is a pre-mRNA splicing modulator of the IKBKAP (inhibitor of Îş light polypeptide gene enhancer in B-cells, kinase complex associated protein) gene. It corrects aberrant IKBKAP splicing in vitro in cellular models of familial dysautonomia and in vivo in transgenic mice. In combination with Phenylbutyric acid (Cat. No. 2682), RECTAS rescues PARK7 aberrant splicing and neuronal cell loss in a midbrain organoid model of familial Parkinson's disease. Orally bioavailable and brain penetrant.
Greener Choice Claims
- Environmental benefits include:
- Ozone-Safe or Safe for the Ozone Layer

Specifications
Specifications
Chemical Name or Material | 2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine |
CAS | 101862-47-9 |
Quantity | 10 mg |
Target | DNA, RNA and Protein Synthesis Compounds |
Molecular Formula | C10H8ClN5O |
Purity | 0.98 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Tocris Bioscience™ RECTAS >
Spot an opportunity for improvement?Share a Content Correction